LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.25 Consensus Price Target from Analysts

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) have received an average recommendation of “Hold” from the six brokerages that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and two have issued a buy recommendation on the company. The average 12 month price objective among analysts that have covered the stock in the last year is $8.25.

A number of brokerages have issued reports on LFST. UBS Group cut their target price on LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating on the stock in a research report on Thursday, August 15th. Barclays cut their target price on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating on the stock in a research report on Friday, August 9th.

Insider Activity at LifeStance Health Group

In related news, insider Ann Varanakis sold 5,269 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $6.28, for a total transaction of $33,089.32. Following the sale, the insider now directly owns 263,007 shares of the company’s stock, valued at approximately $1,651,683.96. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 6.60% of the company’s stock.

Institutional Investors Weigh In On LifeStance Health Group

Institutional investors and hedge funds have recently made changes to their positions in the company. ProShare Advisors LLC increased its position in LifeStance Health Group by 8.5% in the first quarter. ProShare Advisors LLC now owns 19,069 shares of the company’s stock worth $118,000 after buying an additional 1,500 shares during the period. Bessemer Group Inc. increased its position in LifeStance Health Group by 43.4% in the first quarter. Bessemer Group Inc. now owns 9,143 shares of the company’s stock worth $56,000 after buying an additional 2,768 shares during the period. Victory Capital Management Inc. increased its position in LifeStance Health Group by 27.0% in the second quarter. Victory Capital Management Inc. now owns 14,407 shares of the company’s stock worth $71,000 after buying an additional 3,063 shares during the period. SG Americas Securities LLC increased its position in LifeStance Health Group by 8.7% in the first quarter. SG Americas Securities LLC now owns 44,925 shares of the company’s stock worth $277,000 after buying an additional 3,600 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its position in LifeStance Health Group by 12.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 42,366 shares of the company’s stock worth $262,000 after buying an additional 4,681 shares during the period. 85.50% of the stock is owned by institutional investors and hedge funds.

LifeStance Health Group Trading Down 1.5 %

Shares of NASDAQ:LFST opened at $6.71 on Tuesday. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.20. LifeStance Health Group has a 1 year low of $4.64 and a 1 year high of $9.20. The stock has a 50-day simple moving average of $6.84 and a 200-day simple moving average of $6.17.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01. The firm had revenue of $312.30 million during the quarter, compared to analysts’ expectations of $305.85 million. LifeStance Health Group had a negative return on equity of 10.51% and a negative net margin of 13.05%. LifeStance Health Group’s quarterly revenue was up 20.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.13) EPS. As a group, sell-side analysts forecast that LifeStance Health Group will post -0.24 EPS for the current year.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.